Publication | Closed Access

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

Metastatic Breast CancerBreast OncologyVersus CyclophosphamideMedicinePharmacologyPhase Iii TrialBreast CancerPharmacotherapyCancer TreatmentOncologyRadiation Oncology